1. Roche's risdiplam deal a relief for SMA rivals Biogen and Novartis--for now— AstraZeneca targets summer start for COVID-19 antibody trial — Keros Therapeutics raises $96M in upsized IPO — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Watch out for TransEnterix Senhance! Coming after ALL the Business!

Discussion in 'Intuitive Surgical Patient Discussions' started by anonymous, May 29, 2018 at 12:18 PM.

  1. anonymous

    anonymous Guest

    Watch out for TransEnterix! FDA extension approval!!!!